Literature DB >> 30776555

Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells.

Chengli Yang1, Qiongli Xie1, Xian Zeng1, Nengyin Tao1, Yingshu Xu1, Yongzheng Chen1, Jing Wang2, Lei Zhang3.   

Abstract

In this study, three hybrids of podophyllotoxin and formononetin were synthesized and evaluated for anticancer efficacy. Some of the derivatives exhibited potent cytotoxicity against a panel of human and mouse cancer cell lines, with IC50 values in the low micromolar to submicromolar range. Evaluation against A549 lung tumor cell line identified that the IC50 value of compound 10a was 0.753 μM, indicating that 10a was 2.568-fold more efficacious than parent podophyllotoxin. Mechanistic studies revealed that 10a induced A549 cell apoptosis mainly via caspase pathway, as well as disrupted the microtubule organization by occupying the colchicine binding site of the tubulin. Moreover, wound healing assay and transwell invasion assay indicated that 10a displayed potent inhibitory effects on invasion and migration in A549 cancer cells. In additiona, a decrease in vimentin immunostaining was also observed in A549 cells after treatment with 10a. Overall, hybrid 10a might be a promising candidate for the potential treatment of human lung carcinoma.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Formononetin; Hybridization; Invasion; Migration; Podophyllotoxin

Mesh:

Substances:

Year:  2019        PMID: 30776555     DOI: 10.1016/j.bioorg.2019.02.019

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  4 in total

1.  Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma.

Authors:  Jiajia Cui; Xiwang Zheng; Dongli Yang; Yinghuan Hu; Changming An; Yunfeng Bo; Huizheng Li; Yuliang Zhang; Min Niu; Xuting Xue; Yan Lu; Yemei Tang; Hongyu Yin; Zhenyu Li; Wei Gao; Yongyan Wu
Journal:  RSC Adv       Date:  2019-08-07       Impact factor: 4.036

2.  Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer.

Authors:  Xinyou Yu; Feng Gao; Wei Li; Li Zhou; Wenbin Liu; Ming Li
Journal:  J Exp Clin Cancer Res       Date:  2020-04-10

3.  Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity.

Authors:  Zhongtao Yang; Zitong Zhou; Xiai Luo; Xiaoling Luo; Hui Luo; Lianxiang Luo; Weiguang Yang
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

Review 4.  Focus on Formononetin: Anticancer Potential and Molecular Targets.

Authors:  Samantha Kah Ling Ong; Muthu K Shanmugam; Lu Fan; Sarah E Fraser; Frank Arfuso; Kwang Seok Ahn; Gautam Sethi; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2019-05-01       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.